Altruist Biologics Launches Altru-CON™ High-Concentration Formulation Platform to Accelerate Biologics Development

Altruist Biologics China New York

Altru-CON™ harnesses proprietary excipient blends and expertise to maximize drug delivery and stability through high-concentration formulation.The platform can reduce IND timelines to under nine months and achieve stable formulation for up to 200 mg/mL subcutaneous administration.View original content:https://www.prnewswire.co.uk/news-releases/altruist-biologics-launches-altru-con-high-concentration-formulation-platform-to-accelerate-biologics-development-302702704.html